Cargando…

The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context

Tumor associated macrophages (TAMs) are recruited from the circulation to the tumor site, and can undergo a spectrum of phenotypic changes, with two contrasting activation states described in the literature: the M1 and M2 phenotypes. We previously identified a population of TAMs that express prolife...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Michael J., Wolf, Denise, Mukhtar, Rita A., Tandon, Vickram, Yau, Christina, Au, Alfred, Baehner, Frederick, van’t Veer, Laura, Berry, Donald, Esserman, Laura J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812150/ https://www.ncbi.nlm.nih.gov/pubmed/24205370 http://dx.doi.org/10.1371/journal.pone.0079114

Ejemplares similares

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Mukhtar, Rita A., et al.
Publicado: (2013)

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
por: Scheepens, Josien C.C., et al.
Publicado: (2021)

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
por: Jones, Ella F., et al.
Publicado: (2020)

Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response
por: Magbanua, Mark Jesus M., et al.
Publicado: (2015)

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial
por: Wolf, Denise M., et al.
Publicado: (2020)

PRoBE the cloud toolkit: finding the best biomarkers of drug response within a breast cancer clinical trial
por: O'Grady, Nicholas, et al.
Publicado: (2021)

Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL
por: Olshen, Adam, et al.
Publicado: (2017)

The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study
por: Abel, Mary Kathryn, et al.
Publicado: (2022)

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity
por: Wolf, Denise M., et al.
Publicado: (2014)

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
por: Yu, Katharine, et al.
Publicado: (2023)

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial
por: Parker, Barbara A., et al.
Publicado: (2023)

Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes
por: Barnes, Laura L., et al.
Publicado: (2023)

The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016)

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk
por: van ‘t Veer, Laura J., et al.
Publicado: (2017)

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial
por: Wolf, Denise M., et al.
Publicado: (2017)

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer
por: Magbanua, Mark Jesus M., et al.
Publicado: (2018)

Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast
por: Piper, Merisa L., et al.
Publicado: (2019)

4314 The Impact of Axillary Surgery on Recurrence-Free Survival in Invasive Lobular Carcinoma (ILC) of the Breast
por: Abel, Mary Kathryn Reed, et al.
Publicado: (2020)

The Transcriptional Signature in Alveolar Macrophages Dictates Acute Respiratory Distress Outcomes
por: Tejwani, Vickram, et al.
Publicado: (2019)

Antigenic variation in African trypanosomes: the importance of chromosomal and nuclear context in VSG expression control
por: Glover, Lucy, et al.
Publicado: (2013)

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
por: Engebraaten, Olav, et al.
Publicado: (2021)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Esserman, Laura J., et al.
Publicado: (2011)

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Magbanua, Mark Jesus M., et al.
Publicado: (2021)

Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy
por: Chitalia, Rhea, et al.
Publicado: (2023)

Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief
por: Khoury, Amal L., et al.
Publicado: (2021)

Toward developing a metastatic breast cancer treatment strategy that incorporates history of response to previous treatments
por: Olow, Aleksandra K., et al.
Publicado: (2021)

Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy
por: Rothschild, Harriet T., et al.
Publicado: (2023)

A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients
por: Molloy, Timothy J., et al.
Publicado: (2012)

Extended Abdominal Pedicled Flap Using a Modified Abdominoplasty Incision for Reconstruction of an Extensive Forearm Defect
por: Adidharma, Widya, et al.
Publicado: (2022)

The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database
por: Rothschild, Harriet T, et al.
Publicado: (2023)

A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets
por: Lai, Carmen, et al.
Publicado: (2006)

The WISDOM Study: breaking the deadlock in the breast cancer screening debate
por: Esserman, Laura J.
Publicado: (2017)

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
por: Yau, Christina, et al.
Publicado: (2010)

The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
por: Eklund, Martin, et al.
Publicado: (2019)

Response to Carter et al.
por: Eklund, Martin, et al.
Publicado: (2020)

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature
por: Johansson, Annelie, et al.
Publicado: (2022)

Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling
por: Ramkumar, Vickram, et al.
Publicado: (2011)

Withdrawal from Genetic Counselling for Cancer
por: Bleiker, Eveline, et al.
Publicado: (2005)

Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes
por: Kaur, Mandeep, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7gk8cnnl5mu6vk85v7416bo6u